Zobrazeno 1 - 10
of 1 045
pro vyhledávání: '"Kami J"'
Autor:
Johannes Duell, Pau Abrisqueta, Marc Andre, Gianluca Gaidano, Eva Gonzales-Barca, Wojciech Jurczak, Nagesh Kalakonda, Anna Marina Liberati, Kami J Maddocks, Tobias Menne, Zsolt Nagy, Olivier Tournilhac, Christian Kuffer, Abhishek Bakuli, Aasim Amin, Konstantin Gurbanov, Gilles Salles
Publikováno v:
Haematologica, Vol 109, Iss 2 (2023)
Tafasitamab, an anti-CD19 immunotherapy, is used with lenalidomide for patients with autologous stem cell transplant-ineligible relapsed/refractory diffuse large B-cell lymphoma based on the results of the phase II L-MIND study (NCT02399085). We repo
Externí odkaz:
https://doaj.org/article/61775e7e540d41329d593e13a342ad7b
Autor:
Joseph H. Azar, John P. Evans, Madison H. Sikorski, Karthik B. Chakravarthy, Selah McKenney, Ian Carmody, Cong Zeng, Rachael Teodorescu, No-Joon Song, Jamie L. Hamon, Donna Bucci, Maria Velegraki, Chelsea Bolyard, Kevin P. Weller, Sarah A. Reisinger, Seema A. Bhat, Kami J. Maddocks, Nathan Denlinger, Narendranath Epperla, Richard J. Gumina, Anastasia N. Vlasova, Eugene M. Oltz, Linda J. Saif, Dongjun Chung, Jennifer A. Woyach, Peter G. Shields, Shan-Lu Liu, Zihai Li, Mark P. Rubinstein
Publikováno v:
JCI Insight, Vol 8, Iss 6 (2023)
We assessed vaccine-induced antibody responses to the SARS-CoV-2 ancestral virus and Omicron variant before and after booster immunization in 57 patients with B cell malignancies. Over one-third of vaccinated patients at the pre-booster time point we
Externí odkaz:
https://doaj.org/article/094df6d1a4bf45e8b2832d1cf020148e
Autor:
Yu Ueda, Laetitia M. M. Duler, Kami J. Elliot, Paul-Michael D. Sosa, Jeffrey A. Roberts, Joshua A. Stern
Publikováno v:
BMC Veterinary Research, Vol 16, Iss 1, Pp 1-12 (2020)
Abstract Background Echocardiography is commonly used for assessing cardiac structure and function in various species including non-human primates. A few previous studies reported normal echocardiographic reference intervals of clinically healthy rhe
Externí odkaz:
https://doaj.org/article/a019eb9311094f31a1ffbe73e519d756
Autor:
Johannes Duell, Kami J. Maddocks, Eva González-Barca, Wojciech Jurczak, Anna Marina Liberati, Sven de Vos, Zsolt Nagy, Aleš Obr, Gianluca Gaidano, Pau Abrisqueta, Nagesh Kalakonda, Marc André, Martin Dreyling, Tobias Menne, Olivier Tournilhac, Marinela Augustin, Andreas Rosenwald, Maren Dirnberger-Hertweck, Johannes Weirather, Sumeet Ambarkhane, Gilles Salles
Publikováno v:
Haematologica, Vol 999, Iss 1 (2021)
Not available.
Externí odkaz:
https://doaj.org/article/87ddd8a6674b4a1a85c63967777aba9a
Autor:
Paolo Strati, Sven de Vos, Jia Ruan, Kami J. Maddocks, Christopher R. Flowers, Simon Rule, Priti Patel, Yan Xu, Helen Wei, Melanie M. Frigault, Roser Calvo, Martin J.S. Dyer
Publikováno v:
Haematologica, Vol 106, Iss 10 (2021)
Externí odkaz:
https://doaj.org/article/307471bf81fb484f9a57ab90161ef810
Autor:
Nyla A. Heerema, Natarajan Muthusamy, Qiuhong Zhao, Amy S. Ruppert, Heather Breidenbach, Leslie A. Andritsos, Michael R. Grever, Kami J. Maddocks, Jennifer Woyach, Farrukh Awan, Meixiao Long, Amber Gordon, Caitlin Coombes, John C. Byrd
Publikováno v:
Haematologica, Vol 106, Iss 6 (2020)
Mutations of the IGH variable region in patients with chronic lymphocytic leukemia (CLL) are associated with a favorable prognosis. Cytogenetic complexity (>3 unrelated aberrations) and translocations have been associated with an unfavorable prognosi
Externí odkaz:
https://doaj.org/article/c1f8c37f9c954bf6a8dafb620cb0ea2a
Autor:
Cecelia R. Miller, Amy S. Ruppert, Nyla A. Heerema, Kami J. Maddocks, Jadwiga Labanowska, Heather Breidenbach, Gerard Lozanski, Weiqiang Zhao, Amber L. Gordon, Jeffrey A. Jones, Joseph M. Flynn, Samantha M. Jaglowski, Leslie A. Andritsos, Kristie A. Blum, Farrukh T. Awan, Kerry A. Rogers, Michael R. Grever, Amy J. Johnson, Lynne V. Abruzzo, Erin K. Hertlein, James S. Blachly, Jennifer A. Woyach, John C. Byrd
Publikováno v:
Blood Advances, Vol 1, Iss 19, Pp 1584-1588 (2017)
Abstract: Ibrutinib is a highly effective targeted therapy for chronic lymphocytic leukemia (CLL). However, ibrutinib must be discontinued in a subset of patients due to progressive CLL or transformation to aggressive lymphoma (Richter transformation
Externí odkaz:
https://doaj.org/article/a325e38f8d5245adac540764291770ba
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 6, p 1207 (2021)
The increasing number of approved therapies for relapsed mantle cell lymphoma (MCL) provides patients effective treatment options, with increasing complexity in prioritization and sequencing of these therapies. Chemo-immunotherapy remains widely used
Externí odkaz:
https://doaj.org/article/d422c310ee4e4b68ab2f902efd6d37a7
Autor:
Wang, Michael, Robak, Tadeusz, Maddocks, Kami J., Phillips, Tycel, Smith, Stephen D., Gallinson, David, Calvo, Roser, Wun, Chuan-Chuan, Munugalavadla, Veerendra, Jurczak, Wojciech
Publikováno v:
In Blood Advances 10 September 2024 8(17):4539-4548